HPVC

Program Overview

It has been well-established that human papillomavirus (HPV) infection causes virtually all cervical cancers and the vast majority of genital warts. HPV infection also causes a substantial portion of other anogenital cancers as well as head and neck cancers in both men and women.� Advances in our understanding of the role of HPV infection in cervical cancer have led to the development of 2 HPV vaccines; both have proven safe and effective for girls and young women in the prevention of precancerous and cancerous lesions of the uterine cervix. One is effective for the prevention of the majority of genital warts in males and females. However, significant barriers exist to the global implementation of HPV prevention strategies that could inhibit worldwide use of vaccination. This symposium will review the global burden of HPV infection, the current and future role of HPV prevention, and worldwide variations in the adoption of prevention strategies.

Educational Objectives

After completing this activity, the participant should be better able to:

• Identify global barriers to HPV prevention and create and apply strategies to decrease the burden of HPV-related diseases
• Assess the health burden of HPV infection and its role in noncervical cancers and other HPV-related diseases
• Summarize the natural history and clinical manifestations of HPV infection in males

Target Audience

This activity has been designed to improve the competence and performance of infectious disease specialists and other health care providers who wish to learn more about reducing the global health burden associated with HPV infection.

Accreditation Statement

SciMed is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

SciMed designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure

All faculty participating in continuing education activities sponsored by SciMed are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentations and materials.

Activity Chairperson

Mark A. Kane, MD, MPH
Retired Director, Children’s Vaccine Program
Program for Appropriate Technology in Health (PATH)
Founding President, Global Fund for Children’s Vaccines
Consultant in Vaccinology
Mercer Island, Washington

Faculty

Maura L. Gillison, MD, PhD
Professor of Medicine
Jeg Coughlin Sr. Chair of Cancer Research
The Ohio State University
James Cancer Hospital and Solove Research Institute
Columbus, Ohio

Joel M. Palefsky, MD
Professor of Medicine
Associate Dean for Clinical and Translational Research
Co-Director, UCSF Clinical and Translational Sciences Institute
University of California, San Francisco
San Francisco, California